The Black Sesame Study Cardiology Willfully Ignored for Fifteen Years
Why an 8.2 mmHg blood pressure reduction from a $0.10/day food gets less press than a new statin drug There’s a 2011 study sitting in Nutrition Journal — open access, peer-reviewed, freely available to anyone with an internet connection — that should, by any honest read of its data, have reshaped how we talk about prehypertension. It didn’t. Fifteen years later, almost nobody has heard of it. I want to explain why that silence is itself the most interesting part of the story. Thirty prehypertensive Thai adults (SBP 120–139 or DBP 80–89) were randomized to either 2.52 g/day of black sesame meal in capsules, or an identical-looking placebo, for four weeks. Double-blind. No one was on antihypertensive medication. Endpoint: blood pressure, plus two biomarkers — malondialdehyde (MDA, a marker of oxidative stress) and serum vitamin E. The results: - Systolic BP dropped 8.2 mmHg in the sesame group (129.3 → 121.0), versus essentially no change in placebo. P < 0.05. (A note on units: blood pressure is reported in millimeters of mercury — mmHg — virtually everywhere in the world, including the US, Thailand, the UK, and continental Europe. Some physiology and ICU contexts also use kilopascals (kPa); 8.2 mmHg ≈ 1.09 kPa. No conversion is needed to interpret this number as a US reader.) - MDA fell by a third in the sesame group (1.8 → 1.2 μmol/L), unchanged in placebo. P < 0.05. - Vitamin E rose 30% in the sesame group (29.4 → 38.2 μmol/L), unchanged in placebo. P < 0.01. - Within the sesame group, change in SBP correlated with change in MDA (R = 0.50), and change in DBP correlated negatively with change in vitamin E (R = -0.55). The biomarkers moved together with the clinical outcome, in the directions the antioxidant hypothesis predicts. - No detected side effects. Let me put 8.2 mmHg in context. Standard antihypertensive monotherapy at typical starting doses — thiazide diuretics, ACE inhibitors, ARBs, calcium channel blockers — produces SBP reductions in the range of 7 to 13 mmHg. An 8.2 mmHg reduction is pharmaceutical-magnitude. Not “nice supplement bump.” Not “directionally encouraging.” It sits squarely inside the range of effects we accept as clinically meaningful and prescribe medications for.